BEAM · Company research
Beam Therapeutics Inc. Common Stock (BEAM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A 25,000-share sale is planned by Beam Therapeutics (BEAM) officer and director John M. Evans. - Stock Titan | A 25,000-share sale is planned by Beam Therapeutics (BEAM) officer and director John M. Evans. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Beam Global Stock Draws Traders As Drone Pivot Accelerates - Timothy Sykes | Beam Global Stock Draws Traders As Drone Pivot Accelerates Timothy Sykes | View source ↗ | Timothy Sykes | Oct 15, 2026 | neutral | 0 | 0.6 |
| Beam Global BEEM Stock In Focus After $24M ScoutDI Drone Deal - StocksToTrade | Beam Global BEEM Stock In Focus After $24M ScoutDI Drone Deal StocksToTrade | View source ↗ | StocksToTrade | Oct 15, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 14, 2026 | neutral | 0 | 0.6 |
| Law firm investigates Beam Therapeutics over po... - Pluang | Law firm investigates Beam Therapeutics over po... Pluang | View source ↗ | Pluang | Oct 13, 2026 | neutral | 0 | 0.6 |
| After one treatment, prescribed starch intake fell 92% from baseline by day 93 in one group. - Stock Titan | After one treatment, prescribed starch intake fell 92% from baseline by day 93 in one group. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Does Trade Secret Lawsuit Change The Bull Case For Beam Therapeutics Stock? - Simply Wall Street | Does Trade Secret Lawsuit Change The Bull Case For Beam Therapeutics Stock? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 8, 2026 | neutral | 0 | 0.6 |
| Beam Global To Acquire ScoutDI For Approximately $24 Million - Pulse 2.0 | Beam Global To Acquire ScoutDI For Approximately $24 Million Pulse 2.0 | View source ↗ | Pulse 2.0 | Oct 8, 2026 | neutral | 0 | 0.6 |
| Beam Global (BEEM) stock price, news, quote and history - Yahoo Finance Singapore | Beam Global (BEEM) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 8, 2026 | neutral | 0 | 0.6 |
| Beam Global (BEEM) Stock Price, News, Quote & History - Yahoo! Finance Canada | Beam Global (BEEM) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| PRME Surges 15% After Winning Arbitration Against Beam — Clears Path To Human Trials For Its Gene-Editing Drug - Stocktwits | PRME Surges 15% After Winning Arbitration Against Beam — Clears Path To Human Trials For Its Gene-Editing Drug Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks? - Stocktwits | CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks? Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Beam Global Shares Are Rising Today — What Is Powering The Renewable Energy Infrastructure Developer's Stock? - Stocktwits | Beam Global Shares Are Rising Today — What Is Powering The Renewable Energy Infrastructure Developer's Stock? Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets - markets.businessinsider.com | Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets markets.businessinsider.com | View source ↗ | markets.businessinsider.com | Oct 7, 2026 | neutral | 0 | 0.6 |
| Drones inspect spaces too dangerous and costly for people to enter. Beam is buying their maker. - Stock Titan | Drones inspect spaces too dangerous and costly for people to enter. Beam is buying their maker. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Beam Global to Acquire ScoutDI for $24 Million, With Earn-Outs Tied to 2026–2027 Revenue - TradingView | Beam Global to Acquire ScoutDI for $24 Million, With Earn-Outs Tied to 2026–2027 Revenue TradingView | View source ↗ | TradingView | Oct 7, 2026 | neutral | 0 | 0.6 |
| Nvidia Backed Reflection AI Launches Its New Beam Model To Compete With Chinese tech rivals - TIKR.com | Nvidia Backed Reflection AI Launches Its New Beam Model To Compete With Chinese tech rivals TIKR.com | View source ↗ | TIKR.com | Oct 6, 2026 | neutral | 0 | 0.6 |
| Beam Therapeutics (BEAM) Stock Looks Fully Valued Despite In Vivo Gene Editing Growth - Simply Wall Street | Beam Therapeutics (BEAM) Stock Looks Fully Valued Despite In Vivo Gene Editing Growth Simply Wall Street | View source ↗ | Simply Wall Street | Sep 24, 2026 | neutral | 0 | 0.6 |
| 8 Red Days In A Row: Beam Therapeutics Stock Is Down 27% - Trefis | 8 Red Days In A Row: Beam Therapeutics Stock Is Down 27% Trefis | View source ↗ | Trefis | Jul 20, 2026 | neutral | 0 | 0.6 |
| BofA reiterates Beam Therapeutics stock rating after arbitration ruling - Investing.com | BofA reiterates Beam Therapeutics stock rating after arbitration ruling Investing.com | View source ↗ | Investing.com | Jul 8, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.